SAN FRANCISCO, Nov. 19, 2025 /PRNewswire/ — The global cell culture media market size is expected to reach USD 12.80 billion by 2033, registering a CAGR of 13.20% from 2025 to 2033, according to a new report by Grand View Research, Inc. Cell culture media, typically a liquid or gel, contain the essential compounds necessary to regulate and support the growth of cells and microorganisms vital for manufacturing biopharmaceuticals. A significant factor driving this market is the increasing reliance on cell culture-based viral vaccines, which are now a critical component of global immunization strategies. These methods offer a safer, more efficient, and scalable alternative to traditional egg-based approaches, ensuring high-quality vaccine production that meets rising global demand and stringent safety standards.
The move toward cell-derived vaccines is accelerating due to critical advantages over older methods. For instance, the CDC noted that from 2020 to 2021, flu vaccine viruses supplied to manufacturers were cell-derived to mitigate the risk of antigenic changes, or mismatches between vaccine strains and circulating viruses, that can occur during egg-based cultivation and reduce effectiveness. Furthermore, the FDA’s approval of cell-based candidate vaccine viruses (CVVs) has streamlined the development of more consistent and potentially effective flu vaccines. Beyond influenza, the utility of this technology is broad, extending to the production of vaccines for diseases such as smallpox, rotavirus, rubella, hepatitis, chickenpox, and polio.
Request a free sample copy of this report: Cell Culture Media Market
Innovation in cell culture media also significantly supports the burgeoning field of advanced therapeutics. A notable development occurred in December 2024 when Mesoblast received FDA approval for Ryoncil (remestemcel-L), marking it as the first and only mesenchymal stromal cell (MSC) therapy approved in the U.S. for treating steroid-refractory acute graft-versus-host disease (SR-aGvHD) in pediatric patients. This breakthrough therapy is also being developed for other inflammatory conditions, such as biologic-resistant inflammatory bowel disease. The ongoing advancements in biological models, continuous refinement of cell culture media, and the trend toward reducing reliance on animal-derived components are expected to sustain and fuel further innovation in the development of both cell-based vaccines and complex cell therapies.
Cell Culture Media Market Report Highlights:
- Based on product, the serum-free media segment dominated the market in 2024 with a 33.16% revenue share, serving as a vital tool that allows researchers to grow specific cell types, enhance consistency and productivity, and significantly reduce the risk of infection.
- The biopharmaceutical production segment led the market in 2024 with a 47.79% revenue share, primarily driven by the industry’s need for more reproducible and defined media to support expanding production and minimize contamination risks in downstream processes.
- Based on end use, the hospital and diagnostic laboratory segment is projected for significant growth, driven by the increasing use of cell culture media in diagnostic testing and the rising global prevalence of chronic diseases like cancer and autoimmune disorders.
- North America dominated the market in 2024 with a 38.57% share, primarily attributed to the significant growth of its pharmaceutical and biotechnology industries. This leading position is further reinforced by increasing approvals for cell culture-based vaccines, a rising incidence of diseases like cancer, and substantial investments in cell-based research and development.
Read full market research report on Cell Culture Media Market with TOC – Cell Culture Media Market Size, Share & Trends Analysis Report By Product (Serum-free Media, Classical Media), By Type (Liquid Media, Semi-solid & Solid Media), By Application (Biopharmaceutical Production), By End-use, By Region, And Segment Forecasts, 2025 – 2033
Cell Culture Media Market Segmentation
Grand View Research has segmented the global cell culture media market based on product, application, type, end use, and region:
Cell Culture Media Market – Product Outlook (Revenue, USD Million, 2021 – 2033)
- Serum-free Media
- CHO Media
- BHK Medium
- Vero Medium
- HEK 293 Media
- Other Serum-free media
- Classical Media
- Stem Cell Culture Media
- Mesenchymal Stem Cells (MSCs)
- Hematopoietic Stem Cells (HSCs)
- Induced Pluripotent Stem Cells (iPSCs)
- Other Stem Cells
- Immunology Media
- T Cells
- B Cells
- Natural Killer (NK) Cells
- Other Immune Cells
- Specialty Media
- Chemically Defined Media
- Other Cell Culture Media
Cell Culture Media Market – Application Outlook (Revenue, USD Million, 2021 – 2033)
- Biopharmaceutical Production
- Monoclonal Antibodies
- Vaccines Production
- Other Therapeutic Proteins
- Diagnostics
- Drug Screening and Development
- Tissue Engineering and Regenerative Medicine
- Cell and Gene Therapy
- Other Tissue Engineering and Regenerative Medicine Applications
- Other Applications
Cell Culture Media Market – Type Outlook (Revenue, USD Million, 2021 – 2033)
- Liquid Media
- Semi-solid and Solid Media
Cell Culture Media Market – End Use Outlook (Revenue, USD Million, 2021 – 2033)
- Pharmaceutical and Biotechnology Companies
- Hospitals and Diagnostic Laboratories
- Research and Academic Institutes
- Other End uses
Cell Culture Media Market – Regional Outlook (Revenue, USD Million, 2021 – 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East and Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
List of Key Players in the Cell Culture Media Market
- Sartorius AG
- Danaher
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- FUJIFILM Corporation
- Lonza
- BD
- STEMCELL Technologies
- Cell Biologics, Inc.
- PromoCell GmbH
Check out more related studies published by Grand View Research:
- Cell Culture Media & Cell Lines Market – The global cell culture media & cell lines market is projected to reach USD 11.25 billion by 2033, growing at a CAGR of 9.63% during the forecast period, according to a new report by Grand View Research, Inc. The market of cell culture media & cell lines is experiencing robust growth, driven by the expanding demand for biologics, cell and gene therapies, regenerative medicine, and advanced vaccine platforms. As biopharmaceutical R&D intensifies globally, there is a growing need for optimized, high-performance media formulations and validated cell lines that ensure consistency, scalability, and regulatory compliance across diverse applications.
- Cell Culture Media Storage Containers Market – The global cell culture media storage containers market size is anticipated to reach USD 4.26 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 12.55% from 2025 to 2030. Cell culture media storage containers are equipment or vessels built exclusively for storing cell culture media. The cell culture media containers have been developed to meet the unique needs of cell culture, for example maintaining a sterile environment, reducing evaporation, and protecting against light and temperature variations. Increasing R&D efforts, rising demand for biopharmaceuticals, and technical advances in the industry are propelling market expansion.
- Cell Culture Market – The global cell culture market size is expected to reach USD 53.17 billion by 2033, registering a CAGR of 11.21% from 2025 to 2033, according to a new report by Grand View Research, Inc. The novel three-dimensional cell culture techniques and the growing need for them in biopharmaceutical development, vaccine production, and the rising global demand for advanced therapy medicinal products are expected to drive the market during the forecast period. The COVID-19 pandemic has increased vaccine development activities, especially in the novel mRNA and DNA vaccines space. Vaccine production at a large scale generates a high demand for vectors produced using cell culture techniques.
- Cell Culture Vitamins Market – The global cell culture vitamins market size is expected to reach USD 343.0 million by 2030 and is expected to grow at 5.6% CAGR from 2025 to 2030, according to a new report by Grand View Research, Inc. The market has experienced considerable growth as there is an increase in reliance on cell culture technologies across various sectors, particularly in biopharmaceutical research and development.
Browse Horizon Databook on Cell Culture Media Market – Global Cell Culture Media Market Size & Outlook
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Explore Horizon Databook – The world’s most expansive market intelligence platform developed by Grand View Research. Gain insights from 30K+ Global & Regional Reports, 120K+ Country Reports, 1.2M+ Market Statistics, 200K+ Company Profiles, and 5 business solutions encompassing ESG and Sustainability Consulting, Procurement Intelligence, Pricing Index and Analysis, and Consumer Analytics.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]
Web: https://www.grandviewresearch.com
Blog: https://globalindustryherald.com/
Follow Us: LinkedIn | Twitter
Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg
SOURCE Grand View Research, Inc.
